MiRNAs of Peripheral Blood As the Biomarker of Schizophrenia

Overview

Journal Hereditas

Specialty Genetics

Date 2017 Sep 2

PMID 28860957

Citations 28

Authors

Kuanjun He

Chuang Guo

Lin He

Yongyong Shi

Affiliations

Soon will be listed here.

Abstract

The diagnosis of schizophrenia is currently based on the symptoms and bodily signs rather than on the pathological and physiological markers of the patient. In the search for new molecular targeted therapy medicines, and recurrence of early-warning indicators have become the major focus of contemporary research, because they improve diagnostic accuracy. Biomarkers reflect the physiological, physical and biochemical status of the body, and so have extensive applicability and practical significance. The ascertainment of schizophrenia biomarkers will help diagnose, stratify of disease, and treat of schizophrenia patients. The detection of biomarkers from blood has become a promising area of schizophrenia research. Recently, a series of studies revealed that, MiRNAs play an important role in the genesis of schizophrenia, and their abnormal expressions have the potential to be used as biomarkers of schizophrenia. This article presents and summarizes the value of peripheral blood miRNAs with abnormal expression as the biomarker of schizophrenia.

Citing Articles

The Correlation Between Peripheral Blood Micro-Ribonucleic Acid Expression Level and Personality Disorder in Patients with Schizophrenia.

Wei H, Kong L, Zhu X, Chen S, Zhang L, Niu W Alpha Psychiatry. 2024; 25(1):23-29.

PMID: 38799488 PMC: 11114240. DOI: 10.5152/alphapsychiatry.2024.231216.

The emerging roles of microbiota-derived extracellular vesicles in psychiatric disorders.

Guo C, Bai Y, Li P, He K Front Microbiol. 2024; 15:1383199.

PMID: 38650872 PMC: 11033316. DOI: 10.3389/fmicb.2024.1383199.

An In Vitro Study for the Role of Schizophrenia-Related Potential miRNAs in the Regulation of COMT Gene.

Tonk O, Tokgun P, Yilmaz O, Tokgun O, Inci K, Celikkaya B Mol Neurobiol. 2024; 61(10):7680-7690.

PMID: 38427212 PMC: 11415445. DOI: 10.1007/s12035-024-04070-2.

Blood-Based MicroRNAs in Psychotic Disorders-A Systematic Review.

Grosu S, Dobre M, Milanesi E, Hinescu M Biomedicines. 2023; 11(9).

PMID: 37760977 PMC: 10525934. DOI: 10.3390/biomedicines11092536.

From Plants to Psycho-Neurology: Unravelling the Therapeutic Benefits of Bioactive Compounds in Brain Disorders.

Grosso C, Santos M, Barroso M Antioxidants (Basel). 2023; 12(8).

PMID: 37627598 PMC: 10451187. DOI: 10.3390/antiox12081603.

References

Nuzzo D, Picone P, Caruana L, Vasto S, Barera A, Caruso C . Inflammatory mediators as biomarkers in brain disorders. Inflammation. 2013; 37(3):639-48. DOI: 10.1007/s10753-013-9780-2. View

Kim A, Parker E, Williamson V, McMichael G, Fanous A, Vladimirov V . Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. Schizophr Res. 2012; 141(1):60-64. PMC: 4104606. DOI: 10.1016/j.schres.2012.06.038. View

Valles A, Martens G, de Weerd P, Poelmans G, Aschrafi A . MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia. J Psychiatry Neurosci. 2014; 39(5):312-20. PMC: 4160360. DOI: 10.1503/jpn.130269. View

Moreau M, Bruse S, David-Rus R, Buyske S, Brzustowicz L . Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry. 2010; 69(2):188-93. PMC: 3038345. DOI: 10.1016/j.biopsych.2010.09.039. View

. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011; 43(10):969-76. PMC: 3303194. DOI: 10.1038/ng.940. View

Sun X, Lu J, Zhang L, Song H, Zhao L, Fan H . Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients. J Clin Neurosci. 2014; 22(3):570-4. DOI: 10.1016/j.jocn.2014.08.018. View

Guo A, Sun J, Jia P, Zhao Z . A novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC Syst Biol. 2010; 4:10. PMC: 2834616. DOI: 10.1186/1752-0509-4-10. View

Pickard B . Schizophrenia biomarkers: translating the descriptive into the diagnostic. J Psychopharmacol. 2015; 29(2):138-43. DOI: 10.1177/0269881114566631. View

Popov N, Stoyanova V, Madzhirova N, Vachev T . Epigenetic aspects in schizophrenia etiology and pathogenesis. Folia Med (Plovdiv). 2012; 54(2):12-6. DOI: 10.2478/v10153-011-0082-x. View

10.

de la Morena M, Eitson J, Dozmorov I, Belkaya S, Hoover A, Anguiano E . Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome. Clin Immunol. 2013; 147(1):11-22. PMC: 3748608. DOI: 10.1016/j.clim.2013.01.011. View

11.

Santarelli D, Beveridge N, Tooney P, Cairns M . Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry. 2010; 69(2):180-7. DOI: 10.1016/j.biopsych.2010.09.030. View

12.

Guan F, Zhang B, Yan T, Li L, Liu F, Li T . MIR137 gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese. Schizophr Res. 2013; 152(1):97-104. DOI: 10.1016/j.schres.2013.11.004. View

13.

Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

14.

Hamshere M, Walters J, Smith R, Richards A, Green E, Grozeva D . Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry. 2012; 18(6):708-12. PMC: 4724864. DOI: 10.1038/mp.2012.67. View

15.

Messias E, Chen C, Eaton W . Epidemiology of schizophrenia: review of findings and myths. Psychiatr Clin North Am. 2007; 30(3):323-38. PMC: 2727721. DOI: 10.1016/j.psc.2007.04.007. View

16.

Lai C, Yu S, Hsieh M, Chen C, Chen H, Wen C . MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One. 2011; 6(6):e21635. PMC: 3126851. DOI: 10.1371/journal.pone.0021635. View

17.

Mellios N, Huang H, Baker S, Galdzicka M, Ginns E, Akbarian S . Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry. 2009; 65(12):1006-14. DOI: 10.1016/j.biopsych.2008.11.019. View

18.

Lai C, Lee S, Scarr E, Yu Y, Lin Y, Liu C . Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue. Transl Psychiatry. 2016; 6:e717. PMC: 5068884. DOI: 10.1038/tp.2015.213. View

19.

Mueser K, McGurk S . Schizophrenia. Lancet. 2004; 363(9426):2063-72. DOI: 10.1016/S0140-6736(04)16458-1. View

20.

Alevizos I, Illei G . MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol. 2010; 6(7):391-8. PMC: 3041596. DOI: 10.1038/nrrheum.2010.81. View